OptimeyesTM ist

Expert Simulations | Personalized Results

Diese Webseite verwendet Cookies und auch Google Analytics, um Statistiken zu generieren welche uns helfen Ihnen ein angenehmeres Surfen zu ermöglichen. Weitere Informationen finden Sie in unserem Disclaimer. Durch die Nutzung unserer Seite ohne Veränderungen Ihrer Einstellungen erklären Sie sich mit unserem Gebrauch von Cookies und Google Analytics einverstanden. 

Optimeyes ready to enter the US market

Take away messages:

  • Optimeyes is a software product, delivering a solution to treat low-cylinder astigmatism during femtosecond laser cataract surgery.
  • The FDA decided not to enforce regulatory requirements, therefore Optimeyes™ can be entered into the US market.
  • Optimo Medical is enrolled in the US bootcamp, organized by Innossuise/swissnex
  • During the next months, suitable US distribution partners will be evaluated


Optimo Medical gets support by Innossuise to enter the US market

The US Food and Drug Administration (FDA) has decided not to enforce any regulatory requirements, known as enforcement discretion, for Optimeyes™. Therefore, Optimeyes™ is ready to enter the US market. 

This important step forward opened the doors for Optimo Medical to receive the additional boost of a Swissnex bootcamp program. Swissnex supports Swiss businesses in getting access to the US market. Franziska Steiner Head of Entrepreneurship at swissnex San Francisco: “The software from Optimo Medical combines the Swiss values of precision and hi-tech in the medical field. We are delighted to support Optimo Medical with our program to scale-up their resources to be successful within the US market.”

Dr. Harald P. Studer, co-founder and CEO of Optimo Medical states: “The US market is strategically important to us. No other country has more surgeons using femtosecond laser arcuate keratotomy surgery in the battle against astigmatism. With our software Optimeyes™, we give the  surgeons a breakthrough technology to plan surgical interventions in a patient-specific manner, usually carried out during laser-based cataract surgery. Our sophisticated algorithms are capable of calculating the best possible treatment parameters for the individual eye, which the surgeon then simply plugs-in into the laser software. Compared to traditionally used nomograms, the risk of over-correction and the variability in outcomes are reduced. Following the ongoing global mega-trend of personalized medicine, the procedure is tailored to the individual patient’s anatomy [1].”

Optimeyes™ closes the gap in the lower diopter range of astigmatism treatment (from 0.50 – 2.00 Diopter) needs, with limited overlap to the toric IOL portfolio and is also indicated for astigmatism re-treatments.

During the last months, patient messaging has been simplified and the commercialization tools have been adapted accordingly. “We have listened carefully to the needs of surgeons and patients. The developed toolset has been designed to educate and inform the patient accurately, which is crucial for patients, surgeons, and us. Finally, our product supports ophthalmologists to provide higher patient satisfaction and increases the acceptance of the femtosecond laser surgeries” says Alexander van der Mey, CCO of Optimo Medical.

The company has begun to look for suitable distribution partners in the US and will work closely with US cataract surgeons to implement a tailored education program.



About Swissnex

The swissnex Network is an initiative of the State Secretariat for Education, Research and Innovation and is part of the Confederation’s network abroad managed by the Federal Department of Foreign Affairs. The activities of the swissnex Network are based on a collaborative approach, relying on public and private partnerships and funding. 

swissnex is the launchpad for Swiss startups in the US. Our equity-free startup programs are customized to the needs of entrepreneurs exploring or entering the US market. With over a decade of experience accelerating the international success of companies such as Mindmaze, faceshift, and Ava, we tailor our toolbox sessions to each startup and offer critical business connections. By joining our community of innovators, Swiss startups gain visibility and a home base to succeed in the US.

For more information please visit Swissnex at: https://patwww.swissnexsanfrancisco.org/startups or contact us under: This email address is being protected from spambots. You need JavaScript enabled to view it. 


About Innosuisse

Innosuisse is the Swiss Innovation Promotion Agency. It is a federal entity under public law with a separate legal personality. Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.

Innosuisse offers the Market Validation Camp for established and fledging young entrepreneurs alike: In this camp, you can test the international waters, validate your business idea and investigate the potential success of your products or services in different such as the USA, Brazil, China, India and the United Kingdom (UK).

https://www.innosuisse.ch/inno/en/home/start-and-grow-your-business/start-up-coaching/market-entry-camps.html


References:

[1]     Truffer et al., Optimization of surgical parameters based on patient-specific models: Application to arcuate keratotomy, J Cataract Refractive Surgery 2019